Hexamer Therapeutics, Inc funding

Hexamer Therapeutics, Inc, a biotechnology company based in Pullman, WA, filed a Form D with the SEC on September 15, 2026 and reported $500K raised of a $2.5M offering.

Amount raised$500K

Offering size$2.5M

Filed with the SECSeptember 15, 2026

First saleJuly 7, 2026

IndustryBiotechnology

SecuritiesEquity, Options or warrants

LocationPullman, WA

FoundedMore than 5 years ago

Entity typeCorporation

Investors so far2

Minimum investment—

Revenue rangeDecline to Disclose

View the original Form D on SEC EDGAR ↗ · All rounds filed Sep 15

Other health care rounds in Washington

Key Proteo, Inc.$2.3M · Oct 23Biotechnology Ora Biomedical, Inc.$205K · Nov 13Biotechnology Seattle Neurosound Solutions, Inc.$100K · Sep 22Other Health Care Q-Immune, Inc.$25K · Sep 28Biotechnology